Hybrid bioprinter creates capillary networks narrower than 10 micrometers

AI Summary

A hybrid bioprinter has been developed that can create capillary networks narrower than 10 micrometers, representing a significant advancement in organ transplant technology. This innovation could help address the challenges faced by over 100,000 people awaiting organ transplants in the US and improve transplant success rates.

More than 100,000 people are awaiting an organ transplant in the United States, with a new candidate added to the list every 10 minutes. Even if the transplant is carried out successfully, recipients must take immunosuppressive medications, elevating their risk of broader infections, and adhere to a strict lifestyle for the rest of their lives—all while facing the possibility that their body could reject the donated organ at any time.